Company

Tripair™ developed by Coramaze

Medical Equipment Manufacturing Hilden, Nordrhein-westfalen, De 20 employees

Employees: 20
Contacts: 1
Emails: 1

www.tripairtechnology.com LinkedIn

Tripair™ developed by Coramaze Overview

Headquarters: Hilden, Nordrhein-westfalen, De
Website: www.tripairtechnology.com
Industry: Medical Equipment Manufacturing
Employees: 20
NAICS: Medical Equipment and Supplies Manufacturing

Surgical and Medical Instrument Manufacturing

Surgical Appliance and Supplies Manufacturing

Keywords

Medical devices Cardiovascular medical technology Structural heart valve diseases Medical technology Heart disease Transcatheter tricuspid valve repair Tricuspid Edge to Spacer Repair Structural heart MedTech Tricuspid Regurgitation TR

About Tripair™ developed by Coramaze

Tripair™ is a novel, minimally invasive tricuspid valve repair technology designed to treat tricuspid regurgitation — a condition that affects millions globally, with the vast majority currently remaining untreated. Tripair™ simplifies tricuspid valve repair through an innovative transcatheter edge-to-spacer approach. By overcoming the key challenges of procedural complexity and limited adoption, we are on a mission to make TR treatment as simple as a right heart catheterization — so it can be performed by any interventionalist, anywhere. Tripair™ is developed by Coramaze Technologies, a pre-commercial stage company with offices in Germany and Israel. The technology is currently investigational and not yet available for commercial use.

Tripair™ developed by Coramaze Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage

Tripair™ developed by Coramaze Org Chart

Sample employees and titles

Name	Title	Location	Contact
Christoph Kausch	Managing Partner at Mtip		View
Jacob Van Dam	Director of QA at Coramaze Technologies	Herzliya, Tel Aviv District, Israel	Email
Anne Mathieu	Investment Director at Mtip		View